representative work

MedMen to Acquire PharmaCann for US$682 Million, the Largest Acquisition Transaction in U.S. Cannabis To Date


On October 11, 2018, MedMen Enterprises Inc. and PharmaCann LLC announced that they have entered into a binding letter of intent in which MedMen will acquire PharmaCann in an all-stock transaction valued at US$682 million, the largest acquisition transaction in U.S. cannabis to date.

The resulting company will have a portfolio of cannabis licenses in 12 states and will be licensed for 66 retail stores and 13 cultivation and production facilities.

Cassels is acting for MedMen with a deal team that included Shaun Khullar (Securities and Cannabis).

RELATED EXPERTISE: Cannabis | Mergers & Acquisitions | Securities